# Cancer Cell

Source: https://onco.cc/journals/cancer-cell/  
OnCo record `cancer-cell` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Cancer Cell is Cell Press's dedicated cancer journal, publishing mechanism-rich papers on tumour biology, the microenvironment, resistance and biomarkers, plus the CPTAC proteogenomic atlases.

## Summary

Cancer Cell is Cell Press's dedicated cancer journal, founded in 2002, appearing monthly and published by Cell Press (Elsevier) on a hybrid model. It publishes mechanism-rich papers on tumour biology, the microenvironment, drug resistance and biomarkers, including multi-omic studies such as the CPTAC proteogenomic atlases and TCGA subtype papers and translational biomarker work that often accompanies clinical trials. Its readers are cancer biologists and translational researchers. Within OnCo it is related to the CPTAC consortium and the Cancer Cell source feed and is linked from the biographies of Rui-Hua Xu, Ross Levine, Aaron Schimmer, Frank McCormick, Lajos Pusztai and Michael Taylor, and it is where a reader would look for the mechanistic paper behind a resistance story.

## Fields

- Kind: Journal
- Last checked: 2026-09-09
- Also known as: Cancer Cell; src-cancer-cell
- Publisher: Cell Press (Elsevier)
- Scope: basic cancer biology
- Access: hybrid

## Notes

- Holds: Mechanistic cancer biology, multi-omic atlases and translational studies. Access: Paywalled.

## Sources

- Cell Press: https://www.cell.com

## Connected records

- collections: [CPTAC (Clinical Proteomic Tumor Analysis Consortium)](https://onco.cc/collections/cptac/)
- key papers: [A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications](https://onco.cc/key-papers/paper-wright-lymphgen-genetic-subtypes-dlbcl-cancer-cell-2020/), [Accessories to the crime: functions of cells recruited to the tumor microenvironment](https://onco.cc/key-papers/paper-hanahan-cancer-cell/), [Androgen receptor pathway-independent prostate cancer is sustained through FGF signalling](https://onco.cc/key-papers/paper-bluemn-double-negative-prostate-fgf-mapk-cancer-cell-2017/), [Aneuploidy acts both oncogenically and as a tumor suppressor](https://onco.cc/key-papers/paper-weaver-cancer-cell/), [Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia](https://onco.cc/key-papers/paper-jain-cancer-cell/), [Challenges and opportunities for pancreatic cancer immunotherapy](https://onco.cc/key-papers/paper-bear-pancreatic-immunotherapy-review-cancer-cell-2020/), [Clinical sequencing defines the genomic landscape of metastatic colorectal cancer](https://onco.cc/key-papers/paper-yaeger-metastatic-colorectal-genomic-landscape-cancer-cell-2018/), [Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients](https://onco.cc/key-papers/paper-kahles-cancer-cell/), [Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival](https://onco.cc/key-papers/paper-ozdemir-caf-depletion-accelerates-pancreatic-cancer-cancer-cell-2014/), [Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies](https://onco.cc/key-papers/paper-jiang-fuscc-tnbc-landscape-cancer-cell-2019/), [Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets](https://onco.cc/key-papers/paper-shelley-hwang-cancer-cell-2019/), [Integrated genomic characterization of pancreatic ductal adenocarcinoma](https://onco.cc/key-papers/paper-tcga-pancreatic-integrated-characterisation-cancer-cell-2017/), [Integrated molecular meta-analysis of 1,000 paediatric high-grade and diffuse intrinsic pontine gliomas](https://onco.cc/key-papers/paper-mackay-paediatric-hgg-cancer-cell-2017/), [Integrative genomic profiling of human prostate cancer](https://onco.cc/key-papers/paper-taylor-integrative-genomic-profiling-cancer-cell-2010/), [Intertumoural heterogeneity within medulloblastoma subgroups](https://onco.cc/key-papers/paper-cavalli-medulloblastoma-subtypes-cancer-cell-2017/), [Loss of KDM6A activates super-enhancers to induce gender-specific squamous-like pancreatic cancer and confers sensitivity to BET inhibitors](https://onco.cc/key-papers/paper-andricovich-kdm6a-squamous-pancreatic-cancer-cell-2018/), [Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells](https://onco.cc/key-papers/paper-shelley-hwang-cancer-cell-2014/), [Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups](https://onco.cc/key-papers/paper-pajtler-cancer-cell/), [Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study](https://onco.cc/key-papers/paper-nct05890742-cancer-cell-2025/), [Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities](https://onco.cc/key-papers/paper-gay-sclc-subtypes-inflamed-cancer-cell-2021/), [Reciprocal feedback regulation of PI3K and androgen receptor signalling in PTEN-deficient prostate cancer](https://onco.cc/key-papers/paper-carver-pi3k-ar-reciprocal-feedback-prostate-cancer-cell-2011/), [Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma](https://onco.cc/key-papers/paper-rhim-stroma-restrains-pancreatic-cancer-cell-2014/), [Tensional homeostasis and the malignant phenotype](https://onco.cc/key-papers/paper-paszek-cancer-cell/), [The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth](https://onco.cc/key-papers/paper-de-visser-cancer-cell/), [The somatic genomic landscape of chromophobe renal cell carcinoma (The Cancer Genome Atlas)](https://onco.cc/key-papers/paper-tcga-chromophobe-davis-cancer-cell-2014/), [Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial](https://onco.cc/key-papers/paper-wang-cancer-cell/)
- people: [Aaron D. Schimmer](https://onco.cc/people/aaron-schimmer/), [Frank McCormick](https://onco.cc/people/frank-mccormick/), [Lajos Pusztai](https://onco.cc/people/lajos-pusztai/), [Michael D. Taylor](https://onco.cc/people/michael-taylor/), [Ross L. Levine](https://onco.cc/people/ross-levine/), [Rui-Hua Xu](https://onco.cc/people/xu-rui-hua/), [Wouter de Laat](https://onco.cc/people/wouter-de-laat/)

---
JSON: https://onco.cc/api/v1/entities/cancer-cell.json